Portage Biotech Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018	2017
Selling, General & Admin	8.36	8.82	5.13	1.87	0.86	1.45
Research & Development	8.21	6.77	7.31	4.11	1.91	0.79
Other Operating Expenses	43.86	0	0	0	0	0
Operating Expenses	60.44	15.59	12.44	5.98	2.76	2.24
Operating Income	-60.44	-15.59	-12.44	-5.98	-2.76	-2.24
Interest Expense / Income	0.01	0.04	0.18	0.56	0.09	0.02
Other Expense / Income	62.08	-0.81	2.28	-0.03	0.74	-126
Pretax Income	-122.52	-14.82	-14.89	-6.51	-3.59	123.74
Income Tax	-17.86	4.35	2.3	0.74	0	0
Net Income	-104.67	-19.17	-17.19	-7.25	-3.59	123.74
Shares Outstanding (Basic)	16	13	12	11	5	3
Shares Outstanding (Diluted)	16	13	12	11	5	3
Shares Change	23.42%	11.31%	7.13%	127.22%	78.76%	-
EPS (Basic)	-6.49	-1.29	-1.35	-0.49	-0.55	46.21
EPS (Diluted)	-6.49	-1.29	-1.35	-0.49	-0.55	46.21
Free Cash Flow	-12.08	-6.76	-4.28	-3.71	-0.86	-1.07
Free Cash Flow Per Share	-0.75	-0.52	-0.36	-0.34	-0.18	-0.40
EBITDA	-122.51	-14.77	-14.72	-5.95	-3.51	123.77
Depreciation & Amortization	0	0	0	0	0	0
EBIT	-122.51	-14.77	-14.72	-5.95	-3.51	123.77

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).